InsiderTradr

Vimta Labs Limited (VIMTALABS.BO)

BSE · INR · Healthcare · Diagnostics & Research

₹509.30 (+3.43%) as of

Key statistics

Market cap
22.77B
P/E (TTM)
28.84
Forward P/E
67.37
EPS (TTM)
17.66
Dividend yield
0.41%
52-week range
377.30 – 736.95
Beta
-0.10
Revenue (TTM)
4.21B
Profit margin
18.91%
Volume
7.99k

About Vimta Labs Limited

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; and a testing laboratory for water, alcoholic, and non-alcoholic beverages. In addition, the company offers environmental regulatory services, such as impact assessments and post project monitoring, to various industries, including power, infrastructure, cement, oil and gas, and mining, etc.; and EMI/EMC testing for electronic and electrical products/components. It provides solutions to agriculture, biologics and biosimilars, home and personal care, medical device, specialty chemicals, food, electrical and electronics, nutraceuticals, water and beverages, pharmaceuticals, crop care, environment, health and safety, and packaging industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.

Sector
Healthcare
Industry
Diagnostics & Research
Headquarters
Hyderabad, India
Employees
1,384

vimta.com

Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.

Related stocks